In simple. Cause I am. No matter what data sets are expected, nor the efficacy at dosage levels, nor submissions, omissions or contributions. Gastric, breast, stomach and any cancer. I want to know if that patient improved. That his/her cancer is disappearing due to CF33. That's all and that's it.
There seems to be lots of mumbo jumbo. Lots of patience on the professional outcome.
But really, in the real world. Of all these patients treated so far, In one trial or another, of recent, say 60 days. Isnt there just one positive improvement, just one more kill, that we as investors can hang out hat on? Its seems probably not. And there lies the problem with our SP. I mean we are constantly told how CF33 is the holy grail. But im sure just one nurse out there would have told their hubby. 3 degrees of separation from our next human means that somebody knows something. Or is there something not worth knowing.
So far we've had 1 CR. Didn't this guy get a jab for chicken pox?
Hope IMU get their shite together.
Vent over!!
IMO
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
Why IMU is a multi multi bagger, page-24491
-
- There are more pages in this discussion • 938 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M |
Open | High | Low | Value | Volume |
5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35252 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 1753430 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 717241 | 0.058 |
8 | 1860543 | 0.057 |
3 | 1067860 | 0.056 |
20 | 2643992 | 0.055 |
6 | 1127777 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 1095176 | 20 |
0.061 | 520305 | 5 |
0.062 | 290000 | 4 |
0.063 | 100000 | 1 |
0.064 | 217000 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |